The FDA has handed Incyte a complete response letter for a label expansion of the company’s monoclonal antibody Zynyz over issues at a third-party manufacturing site in Indiana that was formerly owned by Catalent. …
Hope rises for vaccine against hookworm parasite
Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.

